BDWCC
ABBV icon

B&D White Capital Company’s AbbVie ABBV Stock Holding History

B&D White Capital Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,100
Closed -$1.79M – 54
2022
Q4 		$1.79M Buy
+11,100
New +$1.7M 0.45% 33

Other funds holding ABBV

Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

B&D White Capital Company's ABBV Position: Q2 2026 in Review

B&D White Capital Company sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 1,700 shares — an estimated $370K sold.

B&D White Capital Company first reported a position in ABBV in Q4 2020 and held it in 13 quarters. The position peaked at $40.5M in Q2 2023. 2,236 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • B&D White Capital Company reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • B&D White Capital Company sold 1,700 AbbVie shares in Q2 2026, an estimated $370K.
  • B&D White Capital Company first reported a position in AbbVie in Q4 2020 and held it in 13 quarters.
  • B&D White Capital Company's AbbVie position peaked at $40.5M in Q2 2023.
  • 2,236 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on B&D White Capital Company's 13F filing for Q2 2026, filed 31 Jul 2026.